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Abstract
Background: Wolbachia is an extremely widespread bacterial endosymbiont of arthropods and
nematodes that causes a variety of reproductive peculiarities. Parthenogenesis is one such
peculiarity but it has been hypothesised that this phenomenon may be functionally restricted to
organisms that employ haplodiploid sex determination. Using two antibiotics, tetracycline and
rifampicin, we attempted to eliminate Wolbachia from the diplodiploid host Folsomia candida, a
species of springtail which is a widely used study organism.
Results:  Molecular assays confirmed that elimination of Wolbachia  was successfully achieved
through continuous exposure of populations (over two generations and several weeks) to
rifampicin administered as 2.7% dry weight of their yeast food source. The consequence of this
elimination was total sterility of all individuals, despite the continuation of normal egg production.
Conclusion:  Microbial endosymbionts play an obligatory role in the reproduction of their
diplodiploid host, most likely one in which the parthenogenetic process is facilitated by Wolbachia.
A hitherto unknown level of host-parasite interdependence is thus recorded.
Background
The taxonomic assemblage of endosymbiotic Wolbachia
α-protobacteria occurs very commonly in insects, mites,
crustaceans and nematodes [1,2] and is responsible for a
huge variety of reproductive peculiarities. One of the most
common of these peculiarities is the incompatibility of
crosses between infected males and uninfected females
[3], but diverse phenomena including phenotypic male
feminisation [4], male killing [5], and thelytokous parthe-
nogenesis [6] have also been conclusively attributed to
Wolbachia infections. Folsomia candida (Collembola: Isot-
omidae) is a cosmopolitan species of springtail, which is
widely used as a standard organism in toxicological assays
and as a biological marker of soil pollution [7,8].
Although there have been hints that males of the species
may exist [9,10], it is generally accepted that the species is
made up entirely of females [8,11]. Certainly, it is well
established that F. candida reproduces by thelytokous par-
thenogenesis for the vast majority of the time. From kary-
otype studies, we know that F. candida uses a diplodiploid
(XX/XO) mechanism of sex determination [11,12]. F. can-
dida is also host to a strain of Wolbachia which is unique
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from the strains known from other taxa [13]. The effects
upon the hosts of this unique supergroup E of Wolbachia
are yet to be characterised [14].
It has been argued that the Wolbachia that induces parthe-
nogenesis may be functionally restricted to organisms
which have a haplodiploid mechanism of sex determina-
tion [15]. The rationale for this argument is that, in hap-
lodiploids, diploidisation of the unfertilised egg is all that
is required to achieve sustainable parthenogenesis.
Diplodiploid organisms, on the other hand, must also
overcome the additional obstacle of inducing eggs to
develop (a function usually performed by the fertilising
sperm). Whereas we now have many demonstrations of
Wolbachia-induced parthenogenesis in haplodiploids (for
example, see Stouthamer [15] and Weeks and Breeuwer
[16]), to date, we have not been able to obtain good evi-
dence of an equivalent phenomenon in diplodiploid
hosts.
We administered the antibiotics tetracycline and
rifampicin ad libitum in the yeast food source of F. candida
(at dry weight doses of 0% (control), 0.03%, 0.3%, 0.9%
and 2.7%) over two generations. Elimination of Wol-
bachia from this host has failed in the past [13,17] but,
assuming success, three outcomes were judged possible.
(1) If the Wolbachia are the obligatory agents of partheno-
genesis or reproduction, their elimination would render
all-female F. candida entirely sterile. The potential for Wol-
bachia to serve such a critical survival function in the biol-
ogy of a diplodiploid organism has never been shown.
(2) If F. candida possesses an independent mechanism of
parthenogenesis and is able to regulate independently
reproductive developmental processes, production of
females by females could continue even in the absence of
Wolbachia (as happens in other organisms, for example,
see Matsuura et al. [18]).
(3) If males of F. candida do occur (albeit very rarely),
elimination of Wolbachia could conceivably result in pro-
duction of males via a post-zygotic mechanism of sex-
chromosome elimination known from another (distantly
related) collembolan [19]. Of course, the common hap-
lodiploid phenomenon of production of haploid males in
the absence of Wolbachia-enforced diploidisation of the
nucleus can be ruled out for this diplodiploid species. The
discovery of males would raise the possibility of sexual
reproduction, with all its genetic consequences, in a spe-
cies which has hitherto been considered entirely asexual.
Results
Wolbachia infection
We randomly selected 10 adult springtails from second-
generation populations of: (i) the F. candida control treat-
ment (0% antibiotic); (ii) the F. candida high-dose (2.7%)
tetracycline treatment; (iii) the F. candida high-dose
(2.7%) rifampicin treatment; and (iv) the sibling species
Folsomia fimetaria, which has males, reproduces sexually,
and is reputed not to host Wolbachia. We used Wolbachia-
specific primers in polymerase chain reaction (PCR) anal-
yses of the total DNA extracted from each of these 40 indi-
viduals to assess whether the bacteria had been eliminated
(see Methods for details of experimental procedures).
Wolbachia-specific amplification products were not found
in any springtails from the high-dose rifampicin treat-
ment, indicating that this treatment successfully elimi-
nated the bacteria. Similarly, none of the 10 F. fimetaria
individuals tested positive for Wolbachia, and it is thus
indeed likely that the two are not symbiotic. Perhaps sur-
prisingly, all F. candida individuals from the high-dose tet-
racycline treatment tested positive for Wolbachia, along
with all those from the control populations. The previ-
ously reported inefficacy of tetracycline in curing Folsomia
of Wolbachia [13,17] is thus supported.
Population parameters
Clear differences in the population growth rates of high-
dose rifampicin treatments compared with high-dose tet-
racycline treatments were also evident, although these dif-
ferences did not emerge until the second generation
(Figure 1). The growth rate of rifampicin populations dif-
fered significantly between the two generations (F(1,110) =
53.5, P  < 0.001), because of a second-generation dose
effect whereby growth in the 2.7% and 0.9% treatments
was significantly lower than that in the 0.3% treatments
which, in turn, was lower than those in the 0.03% or 0%
treatments (Figure 1). No other differences in growth rate
among the treatments and/or generations were detectable.
Slight differences in growth rate, clutch size and hatching
rate were found among some clones. However, as these
differences did not significantly interact with the effects of
interest (that is, dose, antibiotic type and generational
effects), data have been pooled and clone-specific differ-
ences are not presented.
Clutch size
At week 4 of the first-generation, individuals from the tet-
racycline treatments had a significantly larger mean clutch
size of 44.25 ± 2.39 than individuals from the rifampicin
treatments, which had a mean clutch size of 33.95 ± 1.56
(F(1,118) = 10.29, P = 0.002). No dose effect on clutch size
was detectable in the tetracycline treatments (F4,55 = 1.79,
P = 0.15). However, clutch size was significantly affected
by rifampicin dose (F4,55 = 7.64, P < 0.001), reaching sizes
as low as 27.00 ± 2.15 at the highest 2.7% dose.
Over the 6-month observation period (3 months in which
the diet included 2.7% rifampicin followed by 3 months
in which the diet was antibiotic-free), the clutch size of F.BMC Biology 2009, 7:54 http://www.biomedcentral.com/1741-7007/7/54
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candida differed significantly by month (F5,24 = 5.37, P =
0.002). While clutch size did not differ among the first 4
months (being 27.45 ± 1.56 on average), the sizes
observed in the final 2 months (40.4 ± 3.37 and 42.8 ±
2.13) were significantly greater than those recorded in the
preceding months. In F. fimetaria, the average clutch size
of 13.03 ± 0.68 did not fluctuate significantly across the 6
months.
Hatching rate
The average hatching rate for clutches laid at week 4 of the
first-generation tetracycline treatments was 56.67 ±
3.06%. Hatching rate was not found to be significantly
affected by dose in the tetracycline treatments (F4,55 =
1.82, P = 0.14). However, dose was significant for hatch-
ing rate in the rifampicin populations (F4,55 = 2.76, P =
0.04). Hatching rates at week 4 of the first generation fell
from around 50% for doses of 0.03% and 0.3% to just
28.2 ± 3.9% for the 2.7% rifampicin dose. Hatching rates
were not systematically recorded in the second generation
but this rate was observed to decline rapidly to zero in the
2.7% rifampicin treatments.
Nymph:adult ratio
Marked demographic changes occurred because of pro-
longed exposure to high doses of rifampicin. In the first
generation, the average nymph:adult ratio (in which
higher values indicate a younger, faster-growing popula-
tion) of the tetracycline treatments was very similar to that
of rifampicin treatments (9.12 ± 0.31 versus 8.95 ± 0.29).
Four weeks into the second generation, the average
nymph:adult ratio in the tetracycline treatments was
12.31 ± 0.48, reflecting the increase expected from young,
newly founded populations. In contrast, the nymph:adult
ratio in the second generation of rifampicin populations
at the same stage had dropped to just 6.96 ± 0.67. This
treatment difference in week 4 of the second generation
was already highly significant (F1,118 = 42.13, P < 0.001)
and it had become absolute by 8 weeks, when nymphs
were entirely absent from all the populations exposed to
2.7% rifampcin and 11 of the 16 populations exposed to
0.9% rifampicin. The individuals of these populations
were both devoid of Wolbachia and totally sterile.
During the 6-month observation period, the nymph:adult
ratio remained at 0 for the entire period in F. candida (that
is, zero viable nymphs emerged from the hundreds of eggs
that were laid). In F. fimetaria, nymphs of all instars were
present for all 6 months: the nymph:adult ratio did not
differ significantly across months, being 3.53 ± 0.10 on
average.
Males
Although males were easily identified in populations of F.
fimetaria (the sexual species), they were never found in
any F. candida population.
Discussion
The elimination of microbial symbionts is likely to be
responsible for the sterility observed in F. candida.
(Although we showed that sustained heavy doses of anti-
biotic certainly have negative physiological effects, the fact
that total sterility persists long after the antibiotic treat-
ment has ended demonstrates that the sterility is unlikely
to be due to antibiotic toxicity in itself.) Host sterility is
thus attributable to the removal of a microbial strain that
facilitates parthenogenesis and/or other reproductive
processes. We were careful to distinguish between the
facilitation of parthenogenetic diploidisation of the
zygote and other non-parthenogenetic reproductive
development because it is known that Wolbachia can affect
either of these discrete processes. For example, in several
Trichogramma wasp species, Wolbachia is responsible for
gamete duplication (the parthenogenetic developmental
step that leads to a viable zygote) [6], while, in Asobara tab-
ida, it has the even more fundamental role of facilitating
successful oogenesis by inhibiting cell death [20,21]. We
can rule out the possibility that Wolbachia plays a role in
oogenesis in F. candida because of the continued produc-
tion of sterile eggs in the face of long-term exposure to
rifampicin.
In the current system, we cannot unequivocally attribute
the identity of the sterility-associated microbe to Wol-
bachia: such a definitive identification could only be made
Population growth rate (average ± standard error) measured  across four doses of tetracycline and rifampicin over two  generations Figure 1
Population growth rate (average ± standard error) 
measured across four doses of tetracycline and 
rifampicin over two generations. Note that the x-axis is 
nominal.
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if we had demonstrated that infection of an uninfected
collembolan population with Wolbachia  would lead to
parthenogenesis and/or restoration of reproductive abil-
ity. Nevertheless, there exists excellent evidence to indi-
cate that Wolbachia is the likely culprit. Firstly, we can rule
out another common bacterial agent of reproductive alter-
nation, Cardinium, because this symbiont is absent in F.
candida  [22]. In F. candida,  Wolbachia  bacteria are
extremely abundant within both the early oocyte and the
embryo, and cytological observations hint that Wolbachia
could possibly be involved in producing a diploid zygote
through the prevention of the separation of sister chroma-
tids at meiosis II [17]. We thus suggest that the sterility we
observed occurs because Wolbachia plays the crucial role
of inducing parthenogenesis. An alternative explanation is
that F. candida is independently able to produce a diploid
zygote but that Wolbachia is an obligate mutualist with a
crucial role in reproduction, regardless of whether this
reproduction is asexual or sexual.
Rifampicin had a negative influence on clutch size in F.
candida. We interpret this effect to be a consequence of
physiological impairments that were not unexpected:
rifampicin is known to affect mitochondrial RNA synthe-
sis in eukaryotes at very high concentrations [23]. How-
ever, we note that, while clutch sizes increased to normal
levels within 1 month of cessation of the rifampicin treat-
ment, total sterility continued. This observation indicates
that, while the toxic effects of rifampicin impaired repro-
ductive physiology, these effects are not the cause of steril-
ity. While a similar negative effect on clutch size was not
mirrored in F. fimetaria, our casual observations lead us to
suggest that the high dose of rifampicin was also physio-
logically detrimental in this species but that other traits,
which were not systematically measured, tended to be
affected.
The mode of action of tetracycline is to inhibit protein
synthesis by preventing the association of aminoacyl-
tRNA with the bacterial ribosome [24]. The mode of
action of rifampicin is to disrupt an even earlier step in the
process of protein synthesis: rifampin binds to prokaryo-
tic DNA-dependent RNA polymerase, inhibiting tran-
scription of DNA to messenger RNA and thereby
precluding subsequent translation of RNA to proteins
[25]. This different mode of action may be the cause of
rifampicin's efficacy in curing F. candida of Wolbachia.
Although this study found no evidence for the existence of
males of F. candida, it remains possible that such males do
occur rarely in natural populations [9]. If males are ever
found or, indeed, if females of F. candida are able to cross
with males from a sibling species that is yet to be
described [10], F. Frati, personal communication], future
experiments may shed valuable light on whether Wol-
bachia infection (or its absence) can influence the possi-
bility of sexual reproduction in the extremely common
study species that is F. candida.
This newly discovered role for Wolbachia as an obligate
component of reproduction in a diplodiploid animal
broadens the already diverse repertoire of phenomena
that has been created through the co-evolution of these
bacteria and their multitude of hosts. The obligate symbi-
osis between F. candida and Wolbachia is not seen in other
diplodiploid hosts such as the termite Reticulitermes spera-
tus, which is able to continue to reproduce by an inde-
pendent method of parthenogenesis even after it has been
cured of Wolbachia [18].
Conclusion
Examination of the available evidence on the underlying
cause of the observed post-antibiotic sterility suggests
that, contrary to prior belief, endosymbiont-facilitated
parthenogenesis may not be functionally restricted to
haplodiploids. Future work will shed light on the exact
mechanism by which microbial endosymbionts can ena-
ble parthenogenetic reproduction in diplodiploids. The
most likely agent of this reproductive facilitation is Wol-
bachia. The Wolbachia associated with F. candida belongs
to supergroup E and the current results give the first indi-
cation of what effect this discrete clade of endosymbionts
has on its hosts. Future work may even yield evidence that
the widespread and adaptable symbionts that are Wol-
bachia have achieved yet another evolutionary feat: usur-
pation of sperm's role of inducing an egg to commence
embryonic development.
Methods
Study species
Four clonal populations of F. candida (each established
from a single parthenogenetic female) were used in exper-
iments involving the administration of antibiotics. The
founding individuals were collected from different geo-
graphically isolated field populations in the UK and
France. Populations were fed on a paste of baker's yeast
and kept in sealed containers on a substrate of 10% char-
coal, 90% plaster of Paris at a constant temperature of 21
± 0.2°C and a relative humidity of 100%.
The sibling species, Folsomia fimetaria, which reproduces
exclusively by sexual means [17,26] was obtained from
stock populations maintained at the National Environ-
mental Research Institute, Silkeborg, Denmark. This spe-
cies was used as a speculative negative control for PCR
analyses to detect the presence of Wolbachia. Speculation
that this species does not host Wolbachia was based on the
observations of Frati et al. [10] that sexually reproducing
collembolans that are highly morphologically similar to
F. candida are devoid of endosymbiotic Wolbachia.BMC Biology 2009, 7:54 http://www.biomedcentral.com/1741-7007/7/54
Page 5 of 6
(page number not for citation purposes)
Antibiotic treatment protocols
Two antibiotics, tetracycline (Sigma-Aldrich) and
rifampicin (Sigma-Aldrich), which are known to have dif-
fering modes of action, were combined with the yeast
paste food source and administered ad libitum to experi-
mental populations of F. candida. For each antibiotic, five
dose treatments (measured in percentage dry weight, anti-
biotic:yeast) were imposed: 0% (control), 0.03%, 0.3%,
0.9% and 2.7%. Each of these five dose treatments was
replicated across four populations within each of the four
clones of F. candida to give a total number of 160 experi-
mental populations. After 4 weeks of antibiotic exposure,
20 first-instar nymphs were taken from each experimental
population to give rise to a second generation of 160
experimental populations. These second-generation
nymphs were thus guaranteed to be the progeny of moth-
ers that had been exposed to the antibiotic environment
for at least 18 days prior to laying.
For all experimental populations from both generations,
exact population counts were made on the same day of
every week for the first 4 weeks of treatment. Clutch size
within each replicate population was estimated by isolat-
ing a single adult in a separate rearing container and
counting the number of eggs in the first batch of eggs laid.
Hatching rate was calculated by observing the proportion
of first instar nymphs that emerged from 120 to 150 eggs
randomly selected from each replicate population.
Genital examination was used to assess the presence of
males. For each population, 20 randomly selected adults
were killed and the terminal portion of the abdomen was
mounted in lactophenol such that the fifth ventral tergite
was clearly visible under ×450 magnification.
A 6-month long observation comparing reproduction in
populations of F. candida and F. fimetaria under exposure
to 2.7% rifampicin was also conducted. For the first 3
months of this 6-month period, five populations (with
starting sizes of about 100 individuals) of each species
were exposed to rifampicin. (This exposure was a contin-
uation of a rifampicin treatment which had been initiated
some 4 months earlier.) For the final 3 months of the 6-
month period, the antibiotic was no longer included in
their food source. Each month, the clutch size of one adult
female from each of the eight populations was counted.
The proportion of nymphs to adults was also calculated
for each population on a monthly basis.
PCR assays for presence of Wolbachia
For F. candida, 10 randomly selected adults from each of
the following three second-generation treatments were
subjected to a process of total DNA extraction followed by
selective amplification: (i) control (that is, no antibiotic
exposure); (ii) exposure to 2.7% tetracycline; and (iii)
exposure to 2.7% rifampicin. In addition, a fourth group
of 10 F. fimetaria adults was also analysed. Each individual
was squashed with forceps and incubated at room temper-
ature in 50 μl of aqueous buffer (10 mM Tris, 1 mM eth-
ylenediaminetetraacetic acid and 25 mM sodium
chloride), which also contained 0.2 mg/ml proteinase K.
After 30 minutes incubation time, the proteinase K was
inactivated by heating the mixture to 95°C for 2 minutes.
Two primers named V1 (5'-TTGTAGCCTGCTATGG-
TATAACT-3') and V6 (5'-GAATAGGTTATGATTTTCATGT-
3'), which are specific for the 16S rDNA of all known
strains of W. pipientis [13], were used in the PCR amplifi-
cations. Amplification reactions of 25 μl final volume
were created by adding 2 μl from the extraction to a solu-
tion containing 250 μM of each deoxyribonucleotide tri-
phosphate, 12.5 pM of the two primers and 1 U AmpliTaq
DNA polymerase (Applied Biosystems). The amplifica-
tion profile was that used by Frati et al. [10], and consisted
of an initial denaturation at 95°C for 2 minutes, followed
by 35 cycles of 45 seconds of denaturation at 95°C, 45
seconds of annealing at 52°C and 50 seconds of exten-
sions at 72°C, with a final extension period of 7 minutes
at 72°C. Electrophoresis of amplification products was
conducted on agarose gels containing ethidium bromide.
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